@article{d6f9e197beac4b52bd422732f84c25ad,
title = "ANCA Vasculitis Induction Management During the COVID-19 Pandemic",
keywords = "ANCA vasculitis, COVID pandemic, induction therapy",
author = "Antonio Salas and Sam Kant and Lauren Floyd and Vojt{\v e}ch Kratky and Brix, {Silke R.} and Maria Prendecki and Ulf Sch{\"o}nermarck and Jennifer Scott and Manish Saha and Philipp Gauckler and Tingting Li and Sharma, {Purva D.} and Isabelle Ayoub and Morris, {Adam D.} and Dhaygude, {Ajay P.} and Zdenka Hruskova and Vladimir Tesar and McAdoo, {Stephen P.} and Little, {Mark A.} and Derebail, {Vimal K.} and Poulton, {Caroline J.} and Philip Seo and Andreas Kronbichler and Duvuru Geetha",
note = "Funding Information: US receives grants and nonfinancial support from Alexion Pharma, and grants and nonfinancial support from Ablynx and Chemocentryx. BCT; and personal fees from Vifor Pharma and Alexion. VKD has been a consultant to Novartis, on the advisory board for Bayer and Travere, and received roylaties and honoraria from UpToDate. AK received personal fees from Novartis, Terumo BCT, Miltenyi Biotech, Vifor Pharma, and Alexion. DG has been a consultant to ChemoCentryx and Aurinia. All the other authors declared no competing interests. ",
year = "2021",
month = nov,
doi = "10.1016/j.ekir.2021.08.009",
language = "English (US)",
volume = "6",
pages = "2903--2907",
journal = "Kidney International Reports",
issn = "2468-0249",
publisher = "Elsevier Inc.",
number = "11",
}